Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Preprint servers in lipidology: current status and future role

Preprint servers in lipidology: current status and future role Purpose of reviewPreprinting, or the sharing of non-peer reviewed, unpublished scholarly manuscripts, has exploded in all fields of science and medicine over the past 5 years. We searched the literature and evaluated the posting and uptake of preprint publications in the field of lipidology in bioRxiv and medRxiv servers. We also contacted the editorial offices of 20 journals that publish original research in lipidology to gauge their policies on preprints.Recent findingsAll 20 journals contacted indicated that they accepted preprints. As of 31 May 2021, 473 and 231 preprints in lipidology had been submitted to bioRxiv and medRxiv, respectively. About half of all lipidology preprints were related to cardiovascular, cardiometabolic, and/or metabolic diseases (CVMD) and their risk factors, but at least 12 other disease categories were also represented. 16.9% and 1.08% of medRxiv and bioRxiv preprints, respectively, were related to coronavirus disease 2019 (COVID-19).SummaryAll identified journals accept lipidology themed preprints for submission, removing any barriers authors may have had regarding preprinting. Based on growing experience with preprinting, this trend should encourage increased community feedback and facilitate higher quality lipidology research in the future. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in Lipidology Wolters Kluwer Health

Preprint servers in lipidology: current status and future role

Download PDF
6 pages

Loading next page...
 
/lp/wolters-kluwer-health/preprint-servers-in-lipidology-current-status-and-future-role-yev500SZZe

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0957-9672
eISSN
1473-6535
DOI
10.1097/mol.0000000000000797
Publisher site
See Article on Publisher Site

Abstract

Purpose of reviewPreprinting, or the sharing of non-peer reviewed, unpublished scholarly manuscripts, has exploded in all fields of science and medicine over the past 5 years. We searched the literature and evaluated the posting and uptake of preprint publications in the field of lipidology in bioRxiv and medRxiv servers. We also contacted the editorial offices of 20 journals that publish original research in lipidology to gauge their policies on preprints.Recent findingsAll 20 journals contacted indicated that they accepted preprints. As of 31 May 2021, 473 and 231 preprints in lipidology had been submitted to bioRxiv and medRxiv, respectively. About half of all lipidology preprints were related to cardiovascular, cardiometabolic, and/or metabolic diseases (CVMD) and their risk factors, but at least 12 other disease categories were also represented. 16.9% and 1.08% of medRxiv and bioRxiv preprints, respectively, were related to coronavirus disease 2019 (COVID-19).SummaryAll identified journals accept lipidology themed preprints for submission, removing any barriers authors may have had regarding preprinting. Based on growing experience with preprinting, this trend should encourage increased community feedback and facilitate higher quality lipidology research in the future.

Journal

Current Opinion in Lipidology – Wolters Kluwer Health

Published: Apr 25, 2022

References

  • Preprint servers in kidney disease research: a rapid review
  • The prehistory of biology preprints: a forgotten experiment from the 1960s
  • Citing and reading behaviours in high-energy physics
  • How swamped preprint servers are blocking bad coronavirus research
  • medRxiv: Accessing and searching medRxiv and bioRxiv preprint data in R
  • Proliferation of papers and preprints during the coronavirus disease 2019 pandemic: progress or problems with peer review?
  • Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
  • Dyslipidemia of the metabolic syndrome
  • Dyslipidemia in obesity: mechanisms and potential targets
  • Hypertension and lipids: lipid factors in the hypertension syndrome
  • Serum lipid profile and its association with hypertension in Bangladesh
  • The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities
  • bioRxiv: the preprint server for biology
  • Preprint servers’ policies, submission requirements, and transparency in reporting and research integrity recommendations
  • bioRxiv: Trends and analysis of five years of preprints
  • The relationship between bioRxiv preprints, citations and altimetrics